Sijmen de Vries, Pharming CEO
Updated: FDA approves Pharming drug for ultra-rare immunodeficiency disease
US regulators cleared an ultra-rare drug from Pharming Group, by way of Novartis, on Friday afternoon.
The Dutch biotech said the FDA greenlit leniolisib for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.